Exact Mass: 398.186
Exact Mass Matches: 398.186
Found 500 metabolites which its exact mass value is equals to given mass value 398.186
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
BENZOYLARGININE NITROANILIDE
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D002863 - Chromogenic Compounds D004396 - Coloring Agents
L-365260
L-365260 is an orally active and selective antagonist of non-peptide gastrin and brain cholecystokinin receptor (CCK-B), with Kis of 1.9 nM and 2.0 nM, respectively. L-365260 interacts in a stereoselective and competitive manner with guinea pig stomach gastrin and brain CCK receptors. L-365260 can enhance Morphine analgesia and prevents Morphine tolerance[1][2][3].
Cinncassiol E
Cinncassiol E is found in herbs and spices. Cinncassiol E is a constituent of Cinnamomum cassia (Chinese cinnamon). Constituent of Cinnamomum cassia (Chinese cinnamon). Cinncassiol E is found in herbs and spices.
Kanzonol M
Kanzonol M is found in herbs and spices. Kanzonol M is a constituent of the roots of Glycyrrhiza uralensis (Chinese licorice). Constituent of the roots of Glycyrrhiza uralensis (Chinese licorice). Kanzonol M is found in herbs and spices.
3'-Hydroxy-T2-triol
3-Hydroxy-T2-triol is a mycotoxin produced by Fusarium heterosporu
Eletriptan N-oxide
Eletriptan N-oxide is a metabolite of eletriptan. Eletriptan (also known as eletriptan hydrobromide) is a second generation triptan drug intended for treatment of migraine headaches. It is used as an abortive medication, blocking a migraine attack which is already in progress. Eletriptan is marketed and manufactured by Pfizer Inc. It is sold in the US and Canada under the brand name Relpax, and in several other countries under the brand name Relert. (Wikipedia)
Ptaquiloside
D009676 - Noxae > D002273 - Carcinogens D009676 - Noxae > D009153 - Mutagens
N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea
6-[3-(1-Adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic Acid
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids D000970 - Antineoplastic Agents
BENZOYLARGININE NITROANILIDE
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D002863 - Chromogenic Compounds D004396 - Coloring Agents
Bisantrene
D000970 - Antineoplastic Agents
Moveltipril
3-[1-(3-Aminopropyl)-1H-indol-3-YL]-4-(1-methyl-1H-indol-3-YL)-1H-pyrrole-2,5-dione
D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D004791 - Enzyme Inhibitors
Methyl 4-[(E)-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]benzenesulfonate
Pennicitrinone C
A pyranoxanthene that is 3,5-dihydro-2H-pyrano[4,3,2-kl]xanthene substituted by methyl groups at positions 2R, 3S, 4, and 10, by an oxo group at position 5, by hydroxy groups at positions 8 and 10, and by a (2S,3S)-3-hydroxybutan-2-yl group at position 9. It is a natural product isolated from the fungus Penicillium citrinum B-57. D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
Laccaridione B
An organic heterotricyclic compound that is 1H-benzo[g]isochromene-8,9-dione substituted by an ethoxy group at position 1, hydroxy group at position 10, a methoxy group at position 7 and a 4-methylhex-2-en-2-yl group at position 3. Isolated from the stem of the fruiting bodies of the basidiomycete strain Laccaria amethystea, it exhibits inhibitory activity against proteases.
3beta,4beta,5-Trimethoxy-4-hydroxy- (6:7)-2,2-dimethylpyranoflavan
[4S-(4alpha,4aalpha,5alpha,6alpha)]-4,4a,5,6,7,9-Hexahydro-3,4a,5-trimethyl-9-oxonaphtho[2,3-b]furan-4,6-diyl ester 2-methyl-2-propenoic acid
(2R,3S,4S,9R,12R,13R,14S,15R,16R,17S)-3,4,12,13,15,16-hexahydroxy-2,6,14,17-tetramethyl-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-6-en-11-one
2-amino-5-[2-[[(3S)-2,3-dihydroxy-2-[(1S)-1-hydroxyethyl]butanoyl]oxymethyl]anilino]-5-oxopentanoic acid
11-methoxyneo-oxydiaboline|11-Methoxyneooxydiaboline
((2R)-(3at,6at)-hexahydro-2r,4c-methano-furo[3,2-b]pyrrol-3c-yl)-methyl-carbamic acid (7aS)-1c-acetylamino-7xi-chloro-(7ar)-hexahydro-pyrrolizin-2t-yl ester|Lolidin
(1S*)-1-methoxybromotetrasphaerol|(1S*,2S*,3S*,4S*,5R*,8S*,9S*,12S*,13S*)-8-bromo-2-methoxy-5,9-dimethyl-13-(1-methylethyl)tetracyclo[10.2.1.0(3,12).0(4,9)]pentadecan-5-ol
(1S,5S,6R,7S,9R,10S)-5-methylbutanoyloxy-1,4,9-trihydroxy-2-oxoxanth-11-en-6,12-olide
6-acetyl-3-(3,5-dimethyl-1E,3E-heptadien-7-ol)-9R-hydroxy-8a(R)-methyl-7H-furo[2,3-g]-2-benzopyran-7-one|rotiorinol C
3,4-Teracrylshikonin|Teracryl-shikonin|teracrylshikonin
10-methoxy-19alpha-methyl-2-oxo-(7alphaC2,20alpha)-formosanane-16-carboxylic acid methyl ester|O-methyl-rumberine|Palmirin|palmirine
2alpha-isovaleryloxy-3,8-dioxo-4beta,5alpha-dihydroxy-11-peroxybisabola-7(14),9E-diene
(2R,4S)-2-O-beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranosyl-2,4-pentanediol
3-O-acetyl-4,5-O-di-(2-methylbutyryl)-shikimic acid methyl ester|3-O-acetyl-4,5-O-di-<2-methylbutyryl>-shikimic acid methyl ester
(2E,10R)-tetradecaene-4,6-diyne-1,10,14-triol-1-O-beta-D-glucopyranoside
(S)-2,3-dihydro-8-(3-hydroxy-3-methyl-1-butenyl)-5,7-dimethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one|glypuberol
1,3,7-trihydroxy-2-(3-methyl-2-butenyl)-8-(3-hydroxy-3-methylbutyl)-xanthone
12-senecioyloxytetradeca-2E,8Z,10E-trien-4,6-diyne-1,14-diacetate|atractylodemayne C
17-hydroxy-yohimbane-5,16-dicarboxylic acid 16-methyl ester
4-(3,4,8,9-Tetrahydro-8-isopropenyl-5-methoxy-6-methyl-2H-furo[2,3-h]-1-benzopyran-3-yl)-3-methoxy-1,2-benzenediol
10-hydroxy-11-methoxytabersonine alpha-epoxide|jerantinine B
(S)-2,3-dihydro-2-(3-hydroxy-4-methoxyphenyl)-5,7-dimethoxy-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one|5-O-methylglovanon|5-O-MG
14-angeloyloxy-3beta-hydroxycacalohastin propionate
6-acetyl-3-(5-hydroxy-3,5-dimethyl-1E,3E-heptadienyl)-9R-hydroxy-8a(R)-methyl-7H-furo[2,3-g]-2-benzopyran-7-one|rotiorinol B
1-acetyl-12,18-dihydroxy-11-methoxy-cur-19-en-17-al|Henningsolin
1,4,5,6-tetrahydroxy-7,8-di(3-methylbut-2-enyl)xanthone
(1beta,6alpha)-1,6-dihydroxy-14-O-[(4-hydroxyphenyl)acetyl]eudesma-3,11(13)-dien-12-oic acid gamma-lactone|4-hydroxybenzeneacetic acid rel-[(3aR,5aS,6S,9aR,9bR)-2,3,3a,4,5,5a,6,7,9a,9b-decahydro-6-hydroxy-5a-methyl-3-methylene-2-oxonaphtho[1,2-b]furan-9-yl]methyl ester
18-hydroxy-1-methyl-19-nor-coryn-16-ene-5,17-dicarboxylic acid 5-methyl ester|19-hydroxy-5-methoxycarbonyl-1-methyl-18,19-seco-yohimb-16-en-18-oic acid|Cannagunin C
methyl 5,10-dihydroxy-7-methoxy-1,1,3a-trimethyl-1a,2,3,3a,10c,10d-hexahydro-1H-4-oxacyclobuta[cd]indeno[5,6-a]naphthalene-9-carboxylate
jerantinine F
An indole alkaloid isolated from Tabernaemontana corymbosa, and has been shown to exhibit cytotoxicity against human KB cells.
Ro 31-7549
Isodunnial
Isodunnianol is a natural product found in Illicium simonsii and Illicium dunnianum with data available.
C20H30O8_Picras-4-en-16-one, 1,2,11,12,14,15-hexahydroxy-, (1beta,2alpha,9xi,11beta,12alpha,15beta)
C18H26N2O8_1,5-Dideoxy-3-C-({[2-(gamma-glutamylamino)benzyl]oxy}carbonyl)-L-arabinitol
PTAQUILOSIDE
CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 30 D009676 - Noxae > D002273 - Carcinogens D009676 - Noxae > D009153 - Mutagens
(2R,3S,4S,9R,12R,13R,14S,15R,16R,17S)-3,4,12,13,15,16-hexahydroxy-2,6,14,17-tetramethyl-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-6-en-11-one_major
(2R,3S,4S,9R,12R,13R,14S,15R,16R,17S)-3,4,12,13,15,16-hexahydroxy-2,6,14,17-tetramethyl-10-oxatetracyclo[7.7.1.0²,?.0¹³,¹?]heptadec-6-en-11-one
Ala Ala His Thr
Ala Ala Thr His
Ala Asp Pro Pro
Ala His Ala Thr
Ala His Thr Ala
Ala Pro Asp Pro
Ala Pro Pro Asp
Ala Thr Ala His
Ala Thr His Ala
Asp Ala Pro Pro
Asp Pro Ala Pro
Asp Pro Pro Ala
Glu Gly Pro Pro
Glu Pro Gly Pro
Glu Pro Pro Gly
Gly Glu Pro Pro
Gly His Ser Val
Gly His Val Ser
Gly Pro Glu Pro
Gly Pro Pro Glu
Gly Ser His Val
Gly Ser Val His
Gly Val His Ser
Gly Val Ser His
His Ala Ala Thr
His Ala Thr Ala
His Gly Ser Val
His Gly Val Ser
His Ser Gly Val
His Ser Val Gly
His Thr Ala Ala
His Val Gly Ser
His Val Ser Gly
Pro Ala Asp Pro
Pro Ala Pro Asp
Pro Asp Ala Pro
Pro Asp Pro Ala
Pro Glu Gly Pro
Pro Glu Pro Gly
Pro Gly Glu Pro
Pro Gly Pro Glu
Pro Pro Ala Asp
Pro Pro Asp Ala
Pro Pro Glu Gly
Pro Pro Gly Glu
Ser Gly His Val
Ser Gly Val His
Ser His Gly Val
Ser His Val Gly
Ser Val Gly His
Ser Val His Gly
Thr Ala Ala His
Thr Ala His Ala
Thr His Ala Ala
Val Gly His Ser
Val Gly Ser His
Val His Gly Ser
Val His Ser Gly
Val Ser Gly His
Val Ser His Gly
3'-Hydroxy-T2-triol
Kanzonol M
N5-(2-((((S)-2,3-dihydroxy-2-((S)-1-hydroxyethyl)butanoyl)oxy)methyl)phenyl)glutamine
Berkeleylactone C
Berkeleylactone D
Flumedroxone
N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CB - Corticosteroid derivatives C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclohexyl-N-(2,4-difluorophenyl)- (9CI)
1,6-diisocyanatohexane,2-hydroxyethyl prop-2-enoate,oxepan-2-one
(alphaS)-alpha-[[[Methyl[[2-(1-Methylethyl)-4-thiazolyl]Methyl]amino]carbonyl]amino]-4-Morpholinebutanoic acid Methyl ester
Benzetimide hydrochloride
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists Benzetimide hydrochloride is a muscarinic acetylcholine receptor antagonist. Target: mAChR
4-[4-(4-AMINOMETHYLPHENOXY)-[2,2]BIPYRIDINYL-4-YLOXY]-BENZYLAMINE
Ethylene glycol, diethylene glycol, maleic anhydride, dicyclopentadiene polymer
ethyl 3-[[4-(4-methylpiperazin-1-yl)benzoyl]amino]-5,6-dihydro-4H-pyrrolo[3,4-c]pyrazole-1-carboxylate
(3aS,3aS,8aR,8aR)-2,2-Cyclohexylidenebis[8,8a-dihydro-3aH-indeno[1,2-d]oxazole],99e.e.
Solifenacin hydrochloride
Solifenacin hydrochloride (YM905 hydrochloride) is a muscarinic receptor antagonist, with pKis of 7.6, 6.9 and 8.0 for M1, M2 and M3 receptors, respectively.
4-Tert-butyl-2-[(tert-butylamino)methyl]-6-[5-fluoro-6-(trifluoromethyl)pyridin-3-yl]phenol
Jerantinine B
An indole alkaloid that is tabersonine substituted by a hydroxy group at potition 10, a methoxy group at position 11 and an epoxy group across positions 14 and 15. Isolated from Tabernaemontana corymbosa, it exhibits cytotoxicity against human KB cells.
(1-(2-Morpholin-4-ylethyl)indol-3-yl)-4-methylnaphthalen-1-ylmethanone
Rotiorinol C
An azaphilone that is 9,9a-dihydro-2H-furo[3,2-g]isochromen-2-one substituted by an acetyl group at position 3, a hydroxy group at position 9, a 7-hydroxy-3,5-dimethylhepta-1,3-dien-1-yl group at position 6 and a methyl group at position 9a. It has been isolated from Chaetomium cupreum and exhibits antifungal activity.
2-(2,6-dimethylmorpholine-4-carbonyl)-1-(3-methoxypropyl)pyrido[1,2-a]pyrrolo[2,3-d]pyrimidin-4(1H)-one
4-[6-(1-Adamantyl)-7-hydroxy-2-naphthalenyl]benzoic acid
2-((S)-2-((S)-2-Amino-3-(1H-imidazol-4-yl)propanamido)-3-(1H-indol-3-yl)propanamido)acetic acid
Hydrocinnamic acid, 3,4-bis(trimethylsiloxy)-, trimethylsilyl ester
N-[(1r)-3-(4-Hydroxyphenyl)-1-Methylpropyl]-2-(2-Phenyl-1h-Indol-3-Yl)acetamide
N-{2-[6-(2,4-Diamino-6-ethylpyrimidin-5-YL)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-YL]ethyl}acetamide
Nalpha-[(benzyloxy)carbonyl]-N-[(1R)-4-hydroxy-1-methyl-2-oxobutyl]-L-phenylalaninamide
Bisantrene
D000970 - Antineoplastic Agents C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
3,4,12,13,15,16-Hexahydroxy-2,6,14,17-tetramethyl-10-oxatetracyclo[7.7.1.02,7.013,17]heptadec-6-en-11-one
Methyl 21-hydroxy-5,7-dioxa-2,15-diazaheptacyclo[17.2.2.112,15.01,12.03,11.04,8.019,24]tetracosa-3(11),4(8),9-triene-21-carboxylate
Methyl 4-[(E)-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]benzenesulfonate
N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N-(3-methylphenyl)urea
L-365260 is an orally active and selective antagonist of non-peptide gastrin and brain cholecystokinin receptor (CCK-B), with Kis of 1.9 nM and 2.0 nM, respectively. L-365260 interacts in a stereoselective and competitive manner with guinea pig stomach gastrin and brain CCK receptors. L-365260 can enhance Morphine analgesia and prevents Morphine tolerance[1][2][3].
Chaetoviridin H
An azaphilone that is 6H-furo[2,3-h]isochromene-6,8(6aH)-dione substituted by a 3-hydroxy-2-methylbutanoyl group at position 9, a methyl group at position 6a and a 3-methylpent-1-en-1yl group at position 3. It has been isolated from Chaetomium globosum.
N-[2-(4-Benzyl-piperidin-1-ylmethyl)-3H-benzoimidazol-5-yl]-methanesulfonamide
6,7-dimethoxy-N-[(5-methyl-2-furanyl)methyl]-2-(2-methylpropyl)-1-oxo-4-isoquinolinecarboxamide
N-[3-(3-chlorophenyl)phenyl]-1-(3-oxolanylmethyl)-4-piperidinecarboxamide
N-((S,E)-5-Phenyl-1-(phenylsulfonyl)pent-1-en-3-yl)pyrrolidine-2-carboxamide
7-hydroxy-4-(4-methoxyphenyl)-4,4,5-trimethyl-2-spiro[1,3-diazinane-6,2-3,4-dihydro-2H-1-benzopyran]thione
2-(2,3-dihydro-1,4-benzoxazin-4-yl)-8-methoxy-N-(phenylmethyl)-4-quinazolinamine
N-[[(2R,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-fluoro-N-propan-2-ylbenzamide
N-[[(2S,3S,4R)-1-acetyl-3-[4-(2-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylpropanamide
N-[[(2S,3S,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-fluoro-N-propan-2-ylbenzamide
N-ethyl-3-fluoro-N-[[(2S,3R,4S)-4-(hydroxymethyl)-1-(1-oxopropyl)-3-phenyl-2-azetidinyl]methyl]benzamide
N-[[(2R,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-fluoro-N-propan-2-ylbenzamide
N-[[(2S,3R,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-fluoro-N-propan-2-ylbenzamide
1-[(1R,2aR,8bR)-1-(hydroxymethyl)-2-(4-oxanylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-3,3,3-trifluoro-1-propanone
1-[(1S,2aS,8bS)-1-(hydroxymethyl)-2-(4-oxanylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-3,3,3-trifluoro-1-propanone
[(3aR,4R,9bR)-1-(4-methylphenyl)sulfonyl-8-[(E)-prop-1-enyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
(1R,5S)-3-(1,3-benzodioxol-5-ylmethyl)-7-[4-(2-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
(6R,7S,8S)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-(2-methoxy-1-oxoethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8S)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-(2-methoxy-1-oxoethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8S)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-(2-methoxy-1-oxoethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
N-ethyl-3-fluoro-N-[[(2S,3R,4R)-4-(hydroxymethyl)-1-(1-oxopropyl)-3-phenyl-2-azetidinyl]methyl]benzamide
N-ethyl-3-fluoro-N-[[(2R,3S,4R)-4-(hydroxymethyl)-1-(1-oxopropyl)-3-phenyl-2-azetidinyl]methyl]benzamide
N-ethyl-3-fluoro-N-[[(2R,3S,4S)-4-(hydroxymethyl)-1-(1-oxopropyl)-3-phenyl-2-azetidinyl]methyl]benzamide
N-ethyl-3-fluoro-N-[[(2R,3R,4S)-4-(hydroxymethyl)-1-(1-oxopropyl)-3-phenyl-2-azetidinyl]methyl]benzamide
N-[[(2S,3R,4R)-1-acetyl-3-[4-(2-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylpropanamide
N-[[(2R,3R,4S)-1-acetyl-3-[4-(2-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylpropanamide
N-[[(2R,3S,4S)-1-acetyl-3-[4-(2-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylpropanamide
N-[[(2R,3R,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-4-fluoro-N-propan-2-ylbenzamide
1-[(1S,2aR,8bR)-1-(hydroxymethyl)-2-(4-oxanylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-3,3,3-trifluoro-1-propanone
1-[(1R,2aS,8bS)-1-(hydroxymethyl)-2-(4-oxanylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-3,3,3-trifluoro-1-propanone
(1S,9R,10R,11R)-10-(hydroxymethyl)-12-(1,3-oxazol-4-ylmethyl)-11-(piperidine-1-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
(1R,9S,10S,11S)-10-(hydroxymethyl)-12-(1,3-oxazol-4-ylmethyl)-11-(piperidine-1-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
[(3aS,4S,9bS)-1-(4-methylphenyl)sulfonyl-8-[(E)-prop-1-enyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
(1S,5R)-6-(1,3-benzodioxol-5-ylmethyl)-7-[4-(2-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
(6R,7S,8R)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-(2-methoxy-1-oxoethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7R,8R)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-(2-methoxy-1-oxoethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-(2-methoxy-1-oxoethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-(2-methoxy-1-oxoethyl)-1,4-diazabicyclo[4.2.0]octan-2-one
2-[(3-Acetyloxy-2-hexanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[2,3-Di(butanoyloxy)propoxy-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-(2-pentanoyloxy-3-propanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
(2R,3aR,7S)-7-hydroxy-2,5,7-trimethyl-3a-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[3,7a-dihydro-2H-indene-6,1-cyclopropane]-1-one
9-deoxy-hymatoxin A
An organic heterotetracyclic compound that is isopimarane in which a hydrogen at position 2 of the 13-ethyl substituent has been replaced by a (sulfooxy) group, a double bond has been introduced at the 7-8 position, and the beta-methyl group at position 4 has been oxidised to the corrsponding carboxy group and coupled to position 6 to give a gamma-lactone. Isolated from an avendophytic fungus, Xylaria sp. YM 311647, obtained from Azadirachta indica, it shows potent inhibitory activity against C. albicans and Pyricularia oryzae.
Didesmethyl cariprazine
Didesmethyl cariprazine is a metabolite of Cariprazine and acts as the predominant circulating active moiety. Didesmethyl cariprazine has a long half-life of 1-3 weeks. Cariprazine is a antipsychotic agent candidate that exhibits high affinity for the D3 and D2 receptors, and moderate affinity for the 5-HT1A receptor[1].
MIF-1 (TFA)
MIF-1 TFA (Melanostatin), an endogenous brain peptide, is a potent dopamine receptor allosteric modulator. MIF-1 TFA inhibits melanin formation. MIF-1 TFA blocks the effects of opioid receptor activation to modulate the analgesic effects. MIF-1 TFA accesses from the blood to the CNS by directly crossing the blood-brain barrier (BBB)[1][2][3].